Sivextro FDA Approval History
FDA Approved: Yes (First approved June 20, 2014)
Brand name: Sivextro
Generic name: tedizolid phosphate
Dosage form: Tablets and Injection
Company: Cubist Pharmaceuticals, Inc.
Treatment for: Skin and Structure Infection
Sivextro (tedizolid phosphate) is an oxazolidinone antibiotic drug indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Development Timeline for Sivextro
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.